| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |